Inventor · disambiguated record
Michel De Weers
Also filed as: DE WEERS MICHEL
6 granted patents·8 pending applications·231 citations·filing 2006–2023
86Inventor score
Top patents by PatentIndex Score
14 records- 0198US7829673B2Antibodies against CD38 for treatment of multiple myelomaGENMAB AS·Filed 2006·Granted Nov 9, 2010·148 cites·29 claims
- 0294US9040050B2Combination treatment of CD38-expressing tumorsVAN DE WINKEL JAN·Filed 2007·Granted May 26, 2015·39 cites·68 claims
- 0393US9944711B2Antibodies against human CD38GENMAB AS·Filed 2016·Granted Apr 17, 2018·16 cites·48 claims
- 0491US9249226B2Antibodies against human CD38DE WEERS MICHEL·Filed 2011·Granted Feb 2, 2016·20 cites·52 claims
- 0586US9187565B2Antibodies against CD38 for treatment of multiple myelomaDE WEERS MICHEL·Filed 2010·Granted Nov 17, 2015·8 cites·19 claims
- 0684US2024228662A9Antibodies against cd38 for treatment of multiple myelomaGENMAB AS·Filed 2023·Application pending·0 cites
- 0782US2024165226A1Combination treatment of cd38-expressing tumorsGENMAB AS·Filed 2023·Application pending·0 cites
- 0873US2020114000A1Combination treatment of cd38-expressing tumorsGENMAB AS·Filed 2019·Application pending·0 cites
- 0973US2022204636A1Antibodies against human cd38GENMAB AS·Filed 2021·Application pending·0 cites
- 1072US2015231235A1Combination treatment of cd38-expressing tumorsGENMAB AS·Filed 2014·Application pending·0 cites
- 1167US2020283542A1Antibodies against cd38 for treatment of multiple myelomaGENMAB AS·Filed 2020·Application pending·0 cites
- 1264US11230604B2Antibodies against human CD38GENMAB AS·Filed 2018·Granted Jan 25, 2022·0 cites·119 claims
- 1354US2016130362A1Antibodies against cd38 for treatment of multiple myelomaGENMAB AS·Filed 2015·Application pending·0 cites
- 1447US2009076249A1Antibodies against CD38 for treatment of multiple myelomaDE WEERS MICHEL·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michel De Weers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →